About Us

Empiriko is a biotech company focused on small molecule drug development and enhancing personalized treatment at the point-of-care.

Drug development platform (Biomimiks™)

  • To redesign marketed or failed drugs for better efficacy and safety.

  • Our current drug compounds are focused on antiviral therapies for HIV.

Remote personalized diagnostics platform

  • Personalized Metabolic Fingerprint™ Device – Next generation point-of-care blood testing at home/clinic/hospital for detecting disease, drug effectiveness and adverse reactions.

  • Current focus on CVD, infectious diseases and cancer.

Our Team

Leadership

Pam Randhawa, MPM, CEO & Founder

Pam Randhawa, CEO and Founder of Empiriko, has over 25 years of leadership experience in the healthcare/life sciences industries with expertise ranging from policy, corporate strategy, product development, advanced analytics and marketing for Fortune 500 companies, startups, and government. Prior to founding Empiriko, she co-founded AgroGreen Biofuels, an alternative biofuels technology company using agriculture waste.

Daniel Steinberg M.D., CMO

Daniel Steinberg M.D., Empiriko’s Chief Medical Officer, has been a practicing physician for over 30 years, specializing in allergy/clinical immunology. Prior to pursuing his medical training, Dr. Steinberg worked in the biotechnology industry where he developed interdisciplinary solutions to medical, business and scientific challenges in a variety of clinical and industrial settings.

Scientific Advisory Board

Dennis Ausiello, M.D.

Physician-in-Chief, Emeritus, MGH

Dennis Ausiello, M.D. is the Director of the Center for Assessment Technology and Continuous Health (CATCH), Physician-in-Chief, Emeritus at Massachusetts General Hospital and Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School. Dr. Ausiello served as Chief of Medicine at Mass General from 1996 until his retirement in 2013.

Mukund Chorghade, Ph.D.

President and CSO, THINQ Pharma

Mukund Chorghade, Ph.D. has over 35 years of experience in drug discovery, chemical route selection, process development and formulations design for academic and industry-sponsored research on New Chemical Entities and generics. He currently serves as President and Chief Scientific and Technology Officer, THINQ Pharmaceuticals, where he researches drugs derived from Traditional Indian Medicine.

Eric N. Jacobsen, Ph.D., Professor,

Dept. of Chemistry, Harvard University

Eric N. Jacobsen, Ph.D. is the Sheldon Emery Professor of Chemistry at Harvard University where he has been a faculty member since 1993 and previously served as Chair of the Department of Chemistry and Biology.. Before moving to Harvard, he was at the University of Illinois at Urbana-Champaign University, achieving the rank of Associate Professor.

Sir Richard Roberts, Ph.D., Nobel Laureate

CSO, New England Biolabs

Sir Richard Roberts, Ph.D., an entrepreneur, molecular biologist, and architect of gene-splicing, is the Chief Scientific Officer of New England Biolabs, where he has been a Director of Research since 1992. Before moving to NEB, he was at Cold Spring Harbor Laboratories, where he reached the position of Assistant Director for Research under Dr. James. D. Watson.

Rakesh Suri, M.D., D.Phil.

Medical Advisor, Fountain Life

Rakesh Suri, M.D., D.Phil. is Medical Advisor and former President and Chief Medical Officer at Fountain Life. Prior to this role, Dr. Suri was President of International Operations and a practicing cardiothoracic surgeon at Cleveland Clinic in Ohio. He worked collaboratively to expand "One Cleveland Clinic" in the U.S. and abroad, including Global Business Development and Facilitated Access. He also served as CEO and President of Cleveland Clinic Abu Dhabi.

In Memorium 2013-2021

Robert Grubbs, Ph.D. Nobel Laureate

Professor of Chemistry, California Institute of Technology

Robert H. Grubbs, Ph.D., was the Victor and Elizabeth Atkins Professor of Chemistry at the California Institute of Technology, where he was a faculty member since 1978. Prior to Caltech, he was at Michigan State University achieving the rank of Associate Professor.